FDCTech Restates Q2 2025 Financials, Reveals $15.86M Asset Reduction & Material Control Weaknesses
Summary
FDCTech restated its Q2 2025 financials, revealing significant reductions in assets and equity due to accounting errors and material weaknesses in internal controls, following a non-reliance notice.
Key Events · Corporate Governance and Compliance · FDCT
-
Q2 2025 Financial Restatement
The company restated its unaudited condensed consolidated financial statements for the three and six months ended June 30, 2025, and comparative periods, due to identified errors.
-
Non-Reliance on Prior Financials
The Board concluded that previously issued financials for multiple periods (Q1, Q2, Q3 2025, Q1 2026, FY 2024, FY 2025) should no longer be relied upon, as disclosed in a concurrent 8-K.
-
Significant Financial Adjustments
Total assets decreased by $15.86 million and total stockholders' equity decreased by $7.98 million as of June 30, 2025, compared to previously reported figures. Cash and restricted cash combined also saw a $7.13 million reduction.
-
Material Weaknesses in Internal Controls
The company identified material weaknesses related to subscription receivable classification, stock issuance tracking, restricted cash presentation, and noncontrolling interest allocation.
Analysis · FDCT · Technology
This filing is highly important because it details the restatement of Q2 2025 financial results, which were previously deemed unreliable. The restatements reveal substantial accounting errors, leading to a $15.86 million reduction in total assets and a $7.98 million decrease in total equity as of June 30, 2025. These adjustments, particularly the reclassification of a significant subscription receivable to contra-equity and the proper segregation of client funds, indicate fundamental issues with financial reporting accuracy. The disclosure of multiple material weaknesses in internal controls further underscores the severity of these problems, suggesting systemic deficiencies that could impact future financial reliability. This is part of a broader series of restatements and non-reliance notices, signaling a critical period for the company's financial integrity and investor confidence.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FDCT was trading at $0.06 on OTC in the Technology sector, with a market capitalization of approximately $25.8M. The 52-week trading range was $0.00 to $0.12. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.